CombiMatrix Corp. (NASDAQ: CBMX) Starts Presentation at LD Micro 2017 Invitational
CombiMatrix (NASDAQ: CBMX) provides clinical molecular diagnostic laboratory services in the United States. The company focuses on pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It provides molecular diagnostic services primarily in the areas of reproductive health for the diagnosis of developmental disorders associated with intellectual disability, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company’s testing focuses on advanced technologies, including single nucleotide polymorphism, chromosomal microarray analysis, sequencing, fluorescent in situ hybridization, and high resolution karyotyping. For more information, visit the company's website at www.combimatrix.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides…







